Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Exorcising doubts about religious bioethics.

Crane JK, Putney SB.

Am J Bioeth. 2012;12(12):28-30. doi: 10.1080/15265161.2012.719274. No abstract available.

PMID:
23215928
2.

The location of medial patellofemoral ligament injury in adolescents and children.

Putney SA, Smith CS, Neal KM.

J Pediatr Orthop. 2012 Apr-May;32(3):241-4. doi: 10.1097/BPO.0b013e3182471d72.

PMID:
22411327
3.

Does type of mesh used have an impact on outcomes in laparoscopic inguinal hernia?

Shah BC, Goede MR, Bayer R, Buettner SL, Putney SJ, McBride CL, Oleynikov D.

Am J Surg. 2009 Dec;198(6):759-64. doi: 10.1016/j.amjsurg.2009.04.025.

PMID:
19969126
4.
5.

Recombinant human growth hormone poly(lactic-co-glycolic acid) microsphere formulation development.

Jones AJ, Putney S, Johnson OL, Cleland JL.

Adv Drug Deliv Rev. 1997 Oct 13;28(1):71-84.

PMID:
10837565
6.

Cerebral cell adhesion molecule: a novel leukocyte adhesion determinant on blood-brain barrier capillary endothelium.

Starzyk RM, Rosenow C, Frye J, Leismann M, Rodzinski E, Putney S, Tuomanen EI.

J Infect Dis. 2000 Jan;181(1):181-7.

PMID:
10608765
7.

Enhanced anti-tumor effects with microencapsulated c-myc antisense oligonucleotide.

Putney SD, Brown J, Cucco C, Lee R, Skorski T, Leonetti C, Geiser T, Calabretta B, Zupi G, Zon G.

Antisense Nucleic Acid Drug Dev. 1999 Oct;9(5):451-8.

PMID:
10555152
8.

Production and characterization of fusion proteins containing transferrin and nerve growth factor.

Park E, Starzyk RM, McGrath JP, Lee T, George J, Schutz AJ, Lynch P, Putney SD.

J Drug Target. 1998;6(1):53-64.

PMID:
9769021
9.

Encapsulation of proteins for improved delivery.

Putney SD.

Curr Opin Chem Biol. 1998 Aug;2(4):548-52. Review.

PMID:
9736930
10.

A large-scale process to produce microencapsulated proteins.

Herbert P, Murphy K, Johnson O, Dong N, Jaworowicz W, Tracy MA, Cleland JL, Putney SD.

Pharm Res. 1998 Feb;15(2):357-61. No abstract available.

PMID:
9523328
11.

Improving protein therapeutics with sustained-release formulations.

Putney SD, Burke PA.

Nat Biotechnol. 1998 Feb;16(2):153-7. Review. Erratum in: Nat Biotechnol 1998 May;16(5):478.

PMID:
9487521
12.

The stabilization and encapsulation of human growth hormone into biodegradable microspheres.

Johnson OL, Jaworowicz W, Cleland JL, Bailey L, Charnis M, Duenas E, Wu C, Shepard D, Magil S, Last T, Jones AJ, Putney SD.

Pharm Res. 1997 Jun;14(6):730-5.

PMID:
9210189
13.

In vivo characterization of sustained-release formulations of human growth hormone.

Lee HJ, Riley G, Johnson O, Cleland JL, Kim N, Charnis M, Bailey L, Duenas E, Shahzamani A, Marian M, Jones AJ, Putney SD.

J Pharmacol Exp Ther. 1997 Jun;281(3):1431-9.

PMID:
9190880
14.

Bifunctional fusion between nerve growth factor and a transferrin receptor antibody.

McGrath JP, Cao X, Schutz A, Lynch P, Ebendal T, Coloma MJ, Morrison SL, Putney SD.

J Neurosci Res. 1997 Jan 15;47(2):123-33.

PMID:
9008143
15.

Characterization, receptor mapping and blood-brain barrier transcytosis of antibodies to the human transferrin receptor.

Friden PM, Olson TS, Obar R, Walus LR, Putney SD.

J Pharmacol Exp Ther. 1996 Sep;278(3):1491-8.

PMID:
8819537
16.

A month-long effect from a single injection of microencapsulated human growth hormone.

Johnson OL, Cleland JL, Lee HJ, Charnis M, Duenas E, Jaworowicz W, Shepard D, Shahzamani A, Jones AJ, Putney SD.

Nat Med. 1996 Jul;2(7):795-9.

PMID:
8673926
17.
18.

Peptide from a prokaryotic adhesin blocks leukocyte migration in vitro and in vivo.

Rozdzinski E, Spellerberg B, van der Flier M, Bhattacharyya C, Hoepelman AI, Moran MA, Jarpe A, Putney SD, Starzyk RM, Tuomanen E.

J Infect Dis. 1995 Sep;172(3):785-93.

PMID:
7544820
19.

Inhibition of leukocyte-endothelial cell interactions and inflammation by peptides from a bacterial adhesin which mimic coagulation factor X.

Rozdzinski E, Sandros J, van der Flier M, Young A, Spellerberg B, Bhattacharyya C, Straub J, Musso G, Putney S, Starzyk R, et al.

J Clin Invest. 1995 Mar;95(3):1078-85.

20.
21.

HIV experimental vaccines based on the iscom technology using envelope and GAG gene products.

Akerblom L, Nara P, Dunlop N, Putney S, Morein B.

Biotechnol Ther. 1993;4(3-4):145-61.

PMID:
8292967
22.

How antibodies block HIV infection: paths to an AIDS vaccine.

Putney S.

Trends Biochem Sci. 1992 May;17(5):191-6. Review.

PMID:
1350693
24.

Mutations in the principal neutralization determinant of human immunodeficiency virus type 1 affect syncytium formation, virus infectivity, growth kinetics, and neutralization.

Grimaila RJ, Fuller BA, Rennert PD, Nelson MB, Hammarskjöld ML, Potts B, Murray M, Putney SD, Gray G.

J Virol. 1992 Apr;66(4):1875-83.

25.

Prevention of HIV-1 infection in chimpanzees by gp120 V3 domain-specific monoclonal antibody.

Emini EA, Schleif WA, Nunberg JH, Conley AJ, Eda Y, Tokiyoshi S, Putney SD, Matsushita S, Cobb KE, Jett CM, et al.

Nature. 1992 Feb 20;355(6362):728-30.

PMID:
1741059
26.

Human immunodeficiency virus.

Emini EA, Putney SD.

Biotechnology. 1992;20:309-26. Review.

PMID:
1600383
27.
28.

Priming with T helper cell epitope peptides enhances the antibody response to the envelope glycoprotein of HIV-1 in primates.

Hosmalin A, Nara PL, Zweig M, Lerche NW, Cease KB, Gard EA, Markham PD, Putney SD, Daniel MD, Desrosiers RC, et al.

J Immunol. 1991 Mar 1;146(5):1667-73.

PMID:
1704401
29.

Peptides containing multideterminant clusters of human immunodeficiency virus envelope induce murine and human T-cell responses in diverse histocompatibility types.

Berzofsky JA, Pendleton CD, Clerici M, Ahlers J, Lucey DR, Putney SD, Shearer GM.

Trans Assoc Am Physicians. 1991;104:69-77. No abstract available.

PMID:
1845157
30.

HIV vaccine development: lessons learned to date.

Putney SD.

Biotechnol Ther. 1991;2(1-2):1-7. Review. No abstract available.

PMID:
1726960
31.

Broadly neutralizing antibodies elicited by the hypervariable neutralizing determinant of HIV-1.

Javaherian K, Langlois AJ, LaRosa GJ, Profy AT, Bolognesi DP, Herlihy WC, Putney SD, Matthews TJ.

Science. 1990 Dec 14;250(4987):1590-3. Erratum in: Science 1991 Jan 4;251(4989):13.

PMID:
1703322
32.

Human monoclonal antibody that recognizes the V3 region of human immunodeficiency virus gp120 and neutralizes the human T-lymphotropic virus type IIIMN strain.

Scott CF Jr, Silver S, Profy AT, Putney SD, Langlois A, Weinhold K, Robinson JE.

Proc Natl Acad Sci U S A. 1990 Nov;87(21):8597-601.

33.

Antibody-mediated in vitro neutralization of human immunodeficiency virus type 1 abolishes infectivity for chimpanzees.

Emini EA, Nara PL, Schleif WA, Lewis JA, Davide JP, Lee DR, Kessler J, Conley S, Matsushita S, Putney SD, et al.

J Virol. 1990 Aug;64(8):3674-8.

34.

Epitopes recognized by the neutralizing antibodies of an HIV-1-infected individual.

Profy AT, Salinas PA, Eckler LI, Dunlop NM, Nara PL, Putney SD.

J Immunol. 1990 Jun 15;144(12):4641-7.

PMID:
1693639
35.

Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs.

Takahashi H, Takeshita T, Morein B, Putney S, Germain RN, Berzofsky JA.

Nature. 1990 Apr 26;344(6269):873-5.

PMID:
2184369
36.

A formalin inactivated whole SIV vaccine and a glycoprotein-enriched subunit vaccine confers protection against experimental challenge with pathogenic live SIV in rhesus monkeys.

Murphey-Corb M, Martin LN, Davison-Fairburn B, Montelaro RC, Miller M, West M, Ohkawa S, Baskin GB, Zhang JY, Putney S, et al.

Dev Biol Stand. 1990;72:273-85. No abstract available.

PMID:
2282987
37.

Antigenic variation in HIV.

Putney SD, McKeating JA.

AIDS. 1990;4 Suppl 1:S129-36. Review. No abstract available.

PMID:
2152557
38.

Structural and functional features of the HIV envelope glycoprotein and considerations for vaccine development.

Putney SD, Rusche J, Javaherian K, Matthews T, Bolognesi D.

Biotechnology. 1990;14:81-110. Review. No abstract available.

PMID:
1691670
39.

A formalin-inactivated whole SIV vaccine confers protection in macaques.

Murphey-Corb M, Martin LN, Davison-Fairburn B, Montelaro RC, Miller M, West M, Ohkawa S, Baskin GB, Zhang JY, Putney SD, et al.

Science. 1989 Dec 8;246(4935):1293-7.

PMID:
2555923
40.
41.

A single amino acid interchange yields reciprocal CTL specificities for HIV-1 gp160.

Takahashi H, Merli S, Putney SD, Houghten R, Moss B, Germain RN, Berzofsky JA.

Science. 1989 Oct 6;246(4926):118-21.

PMID:
2789433
42.

Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein.

Javaherian K, Langlois AJ, McDanal C, Ross KL, Eckler LI, Jellis CL, Profy AT, Rusche JR, Bolognesi DP, Putney SD, et al.

Proc Natl Acad Sci U S A. 1989 Sep;86(17):6768-72.

43.

Proliferative T-cell response to HIV envelope glycoprotein in immunized and infected primates and human beings.

Krohn K, Ranki A, Lusso P, Moss B, Ashorn P, Arthur LO, Putney SD, Gallo RC.

J Med Primatol. 1989;18(3-4):363-9.

PMID:
2547967
44.

T cell multideterminant regions in the human immunodeficiency virus envelope: toward overcoming the problem of major histocompatibility complex restriction.

Hale PM, Cease KB, Houghten RA, Ouyang C, Putney S, Javaherian K, Margalit H, Cornette JL, Spouge JL, DeLisi C, et al.

Int Immunol. 1989;1(4):409-15.

PMID:
2484961
45.

Type-restricted neutralization of molecular clones of human immunodeficiency virus.

Looney DJ, Fisher AG, Putney SD, Rusche JR, Redfield RR, Burke DS, Gallo RC, Wong-Staal F.

Science. 1988 Jul 15;241(4863):357-9.

PMID:
3388046
46.

B and T cell reactivities after immunization of macaques with HIV subcomponents.

Wahren B, Chiodi F, Ljunggren K, Putney S, Kurth R, Gallo RC, Fenyö EM.

AIDS Res Hum Retroviruses. 1988 Jun;4(3):199-210.

PMID:
3260790
47.

Baculovirus-expressed gp160 of HIV-1 induces antibodies with isolate-specific binding to a nine-amino acid sequence related to type-specific cell fusion inhibition.

Goudsmit J, Meloen R, Rusche JR, Putney SD.

AIDS. 1988 Jun;2(3):231-2. No abstract available. Erratum in: AIDS 1988 Oct;2(5):following A49.

PMID:
3134924
48.

Characterization of a human immunodeficiency virus neutralizing monoclonal antibody and mapping of the neutralizing epitope.

Matsushita S, Robert-Guroff M, Rusche J, Koito A, Hattori T, Hoshino H, Javaherian K, Takatsuki K, Putney S.

J Virol. 1988 Jun;62(6):2107-14.

49.

Isolation of a functional human gene for brain creatine kinase.

Daouk GH, Kaddurah-Daouk R, Putney S, Kingston R, Schimmel P.

J Biol Chem. 1988 Feb 15;263(5):2442-6.

50.

Supplemental Content

Loading ...
Support Center